InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Driscoll Michael Joseph, Director. Officer active across 1 companies, notably Organogenesis Holdings Inc.. Cumulatively, 2 filings have been recorded. The latest transaction was filed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
020,547 shares0
Class A Common Stock
SEC:0001062993-22-004819:0·
020,547 shares0
Class A Common Stock
SEC:0001062993-22-004819·
2 of 2 declarations
About Driscoll Michael Joseph
Michael Joseph Driscoll is a Board Member at Organogenesis Holdings Inc. He plays a key role in the governance of the company and contributes to strategic decision-making. His expertise in healthcare is an asset for Organogenesis, which specializes in tissue regeneration solutions.
